HomeHealth Sciences Journalvol. 12 no. 1 (2023)

An analytical cross-sectional study on the correlation between patient-doctor relationship and medication adherence of hypertensive Filipinos aged 40-65 in greater Manila Area during the COVID-19 pandemic

Vivien Louise R. Haduca | Aervin Joshua R. Grospe | Kia M. Guerrero | Erika G. Guevara | Winona Gail H. Guevarra | James Carlo B. Guillarte | Raycie A. Gunayon | Junel Christine B. Guzman | Caila Mae B. Havana | Jose Ronilo G. Juangco | Alinaya A. Cordero

 

Abstract:

Introduction Hypertension is a key modifiable risk factor for myocardial infarction and stroke, yet medication adherence remains low. The ongoing COVID-19 pandemic has further complicated the management of chronic diseases like hypertension. This study aimed to explore the correlation between the patient-doctor relationship and medication adherence among hypertensive Filipinos aged 40-65 years in the Greater Manila Area during the pandemic. Methods A cross-sectional study was conducted involving 131 hypertensive Filipino participants. Data were collected through an online survey, assessing participant demographic and medical profiles, medication adherence using the Hill-Bone Compliance Scale (HBCS), and the patient-doctor relationship using the Physician-Doctor Relationship Questionnaire-9 (PDRQ-9). Results Approximately half of the participants demonstrated good adherence to hypertension medication. A weak but significant positive correlation was found between overall medication adherence and the patient-doctor relationship. The duration of anti-hypertensive drug intake also showed a weak positive correlation with medication adherence. Factors such as comorbidities and type of consultation did not significantly impact medication adherence. Conclusion This study emphasizes the significance of the patient-doctor relationship in medication adherence among hypertensive Filipinos during the COVID-19 pandemic. Enhancing communication and trust between patients and physicians can potentially improve medication adherence and overall disease management.



References:

  1. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005;365(9455):217– 23.
  2. American Diabetes Association. Clinical practice recommendations 2005. Accessed October 20, 2022. Diabetes Care 2005; 28: S1–S79.
  3. Lehane E, McCarthy G. An examination of the intentional and unintentional aspects of medication non-adherence in patients diagnosed with hypertension. J Clin Nurs 2007;16(4):698–706.
  4. World Health Organization. Adherence to long term therapies: evidence for action. Geneva: World health organization; 2003. Accessed October 20, 2022.
  5. Ballivian J, Alcaide ML, Cecchini D, Jones DL, Abbamonte JM, Cassetti I. Impact of COVID-19-related stress and lockdown on mental health among people living with HIV in Argentina. J Acquir Immune Def Syndr 2020;85(4):475–82.
  6. Kretchy IA, Asiedu-Danso M, Kretchy JP. Medication management and adherence during the COVID-19 pandemic: Perspectives and experiences from low-and middle-income countries. Res Soc Admin Pharm 2021 Jan;17(1):2023-6.
  7. Hulley SB, Cummings SR, Browner WS, Grady D, Newman TB. Designing clinical research : an epidemiologic approach. 4th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2013. Appendix 6C, page 79. Accessed December 5, 2022. https://sample-size.net/correlation-sample-size/ The Correlation Between Patient-Doctor Relationship and Medication Adherence of Hypertensive Filipinos During the COVID-19 Pandemic
  8. Swiatoniowska-Lonc N, Polanski J, Tanski W, JankowskaPolanska B. Impact of satisfaction with physician–patient communication on self-care and adherence in patients with hypertension: cross-sectional study. BMC Health Serv Res 2020;20(1). doi:10.1186/s12913-020-05912-0
  9. Kim MT, Hill MN, Bone LR, Levine DM. Development and testing of the Hill-Bone compliance to high blood pressure therapy scale. Prog Cardiovasc Nurs 2000;15(3):90-6. doi:10.1111/j.1751-7117.2000.tb00211.x
  10. Porcerelli JH, Murdoch W, Morris P, Fowler S. The patient-doctor relationship questionnaire (PDRQ-9) in primary care: A validity study. J Clin Psychol Med Settings 2014;21(3):291-6. doi:10.1007/s10880-014-9407-2
  11. Mutneja E, Yadav R, Dey AB, Gupta P. Frequency and predictors of compliance among patients taking antihypertensive medicines. Indian Heart J 2020;72(2):136- 9. doi:10.1016/j.ihj.2020.03.008
  12. Kocurek B. Promoting medication adherence in older adults and the rest of us. Diab Spect 2009 Mar; 22(2): 80-4. https://doi.org/10.2337/diaspect.22.2.80
  13. Gomes VTS, Rodrigues RO, Gomes RNS, Gomes MS, Viana LVM, Silva FSE. The doctor-patient relationship in the context of the COVID-19 pandemic. Rev Assoc Med Brasil 2020;66(Suppl. 2):7–9. 10.1590/1806-9282.66.s2.7
  14. Burnier M & Egan BM. Adherence in hypertension: A review of prevalence, risk factors, impact and management. Circ Res 2019;124:1124-40. DOI: 10.1161/ CIRCRESAHA.118.313220
  15. Polinski JM, Kesselheim AS, Frolkis JP, Wescott P, Allen-Coleman C, Fischer MA. A matter of trust: patient barriers to primary medication adherence. Health Educ Res 2014;28(5):755-63. https://doi.org/10.1093/her/cyu023
  16. Chang TJ, Bridges JFP, Bynum M, Jackson JW, Joseph JJ, Fischer MA, Lu B, Donneyong MM. Association between patient-clinician relationships and adherence to antihypertensive medications among black adults: An observational study design. J Am Heart Assoc 2021 Jul 20;10(14):e019943. doi: 10.1161/JAHA.120.019943. Epub 2021 Jul 9.
  17. Schoenthaler A, Knafl GJ, Fiscella K, & Ogedegbe G. Addressing the social needs of hypertensive patients: the role of patient-provider communication as a predictor of medication adherence. Circ Cardiovasc Qual Outcomes 2017; 10:e003659. DOI: 10.1161/ CIRCOUTCOMES.117.003659
  18. Hadi N and Rostami GN. Determinant factors of medication compliance in hypertensive patients of Shiraz, Iran 2004: 292-6.